Mandate

VINGE ADVISES ELOS AB (PUBL) IN CONJUNCTION WITH THE SALE OF FIXTURLASER AB

June 27, 2014

Vinge has advised Elos AB (publ), listed on NASDAQ OMX, Stockholm, in connection with the sale of the shares in Fixturlaser AB to Acoem, a company within the Evolem group. Fixturlaser develops, manufactures and sells geometry and shaft alignment systems for industrial enterprises. The purchase price for the shares amounts to approximately SEK 142 million on a cash and debt free basis.

Vinge’s team primarily consisted of responsible partner Anders Strid, associates Johanna Björnum Nyström (project manager), Emma Kero Ljungberg (VDD manager), Anna Seisling (employment) Anna Hofling Johansson (tax) and Daniel Lennartsson (M&A).

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025